These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


78 related items for PubMed ID: 9419441

  • 21. Monokine-producing cells predominate in the recruitment phase of NOD insulitis while cells producing Th1-type cytokines characterize the effector phase.
    Pilström B, Björk L, Böhme J.
    J Autoimmun; 1997 Apr; 10(2):147-55. PubMed ID: 9185876
    [Abstract] [Full Text] [Related]

  • 22. Intramuscular transfer of naked calcitonin gene-related peptide gene prevents autoimmune diabetes induced by multiple low-dose streptozotocin in C57BL mice.
    Sun W, Wang L, Zhang Z, Chen M, Wang X.
    Eur J Immunol; 2003 Jan; 33(1):233-42. PubMed ID: 12594852
    [Abstract] [Full Text] [Related]

  • 23. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
    Bian Y, Hiraoka S, Tomura M, Zhou XY, Yashiro-Ohtani Y, Mori Y, Shimizu J, Ono S, Dunussi-Joannopoulos K, Wolf S, Fujiwara H.
    Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
    [Abstract] [Full Text] [Related]

  • 24. Tolerance mechanisms in murine autoimmune diabetes induced by anti-ICAM-1/LFA-1 mAb and anti-CD8 mAb.
    Chowdhury SA, Nagata M, Yamada K, Nakayama M, Chakrabarty S, Jin Z, Kotani R, Yokono K.
    Kobe J Med Sci; 2002 Dec; 48(5-6):167-75. PubMed ID: 12657834
    [Abstract] [Full Text] [Related]

  • 25. Genetic and immunological basis of autoimmune diabetes in the NOD mouse.
    Yoshida K, Kikutani H.
    Rev Immunogenet; 2000 Dec; 2(1):140-6. PubMed ID: 11324686
    [Abstract] [Full Text] [Related]

  • 26. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
    Phillips KE, Herring B, Wilson LA, Rickford MS, Zhang M, Goldman CK, Tso JY, Waldmann TA.
    Cancer Res; 2000 Dec 15; 60(24):6977-84. PubMed ID: 11156399
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Intramuscular administration of expression plasmids encoding interferon-gamma receptor/IgG1 or IL-4/IgG1 chimeric proteins protects from autoimmunity.
    Chang Y, Prud'homme GJ.
    J Gene Med; 1999 Dec 15; 1(6):415-23. PubMed ID: 10753067
    [Abstract] [Full Text] [Related]

  • 29. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice.
    Xia CQ, Peng R, Qiu Y, Annamalai M, Gordon D, Clare-Salzler MJ.
    Diabetes; 2007 Aug 15; 56(8):2116-23. PubMed ID: 17496235
    [Abstract] [Full Text] [Related]

  • 30. Regulatory Th2-type T cell lines against insulin and GAD peptides derived from orally- and nasally-treated NOD mice suppress diabetes.
    Maron R, Melican NS, Weiner HL.
    J Autoimmun; 1999 Jun 15; 12(4):251-8. PubMed ID: 10330296
    [Abstract] [Full Text] [Related]

  • 31. Intracellular JNK, p38 MAPK and NF-kappaB regulate IL-25 induced release of cytokines and chemokines from costimulated T helper lymphocytes.
    Wong CK, Li PW, Lam CW.
    Immunol Lett; 2007 Oct 15; 112(2):82-91. PubMed ID: 17719653
    [Abstract] [Full Text] [Related]

  • 32. CD28 costimulation is required not only to induce IL-12 receptor but also to render janus kinases/STAT4 responsive to IL-12 stimulation in TCR-triggered T cells.
    Park WR, Park CS, Tomura M, Ahn HJ, Nakahira Y, Iwasaki M, Gao P, Abe R, Hamaoka T, Fujiwara H.
    Eur J Immunol; 2001 May 15; 31(5):1456-64. PubMed ID: 11465102
    [Abstract] [Full Text] [Related]

  • 33. Changes in B and T lymphocytes associated with mycobacteria-induced protection of NOD mice from diabetes.
    Martins TC, Aguas AP.
    J Autoimmun; 1996 Aug 15; 9(4):501-7. PubMed ID: 8864825
    [Abstract] [Full Text] [Related]

  • 34. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice.
    Rapoport MJ, Jaramillo A, Zipris D, Lazarus AH, Serreze DV, Leiter EH, Cyopick P, Danska JS, Delovitch TL.
    J Exp Med; 1993 Jul 01; 178(1):87-99. PubMed ID: 8315397
    [Abstract] [Full Text] [Related]

  • 35. Administration of IL-4 prevents autoimmune diabetes but enhances pancreatic insulitis in NOD mice.
    Tominaga Y, Nagata M, Yasuda H, Okamoto N, Arisawa K, Moriyama H, Miki M, Yokono K, Kasuga M.
    Clin Immunol Immunopathol; 1998 Feb 01; 86(2):209-18. PubMed ID: 9473384
    [Abstract] [Full Text] [Related]

  • 36. Decreased IL-4 production in new onset type I insulin-dependent diabetes mellitus.
    Berman MA, Sandborg CI, Wang Z, Imfeld KL, Zaldivar F, Dadufalza V, Buckingham BA.
    J Immunol; 1996 Nov 15; 157(10):4690-6. PubMed ID: 8906850
    [Abstract] [Full Text] [Related]

  • 37. Regulatory Th2 response induced following adoptive transfer of dendritic cells in prediabetic NOD mice.
    Feili-Hariri M, Falkner DH, Morel PA.
    Eur J Immunol; 2002 Jul 15; 32(7):2021-30. PubMed ID: 12115623
    [Abstract] [Full Text] [Related]

  • 38. [Defect of TCR-mediated signal pathway of T cells in IDDM patients].
    Li HM, Zhong RQ, Yu JP, Cao LN, Kong XT, Chen WF.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Mar 15; 20(2):222-4. PubMed ID: 15191731
    [Abstract] [Full Text] [Related]

  • 39. CCL4 protects from type 1 diabetes by altering islet beta-cell-targeted inflammatory responses.
    Meagher C, Arreaza G, Peters A, Strathdee CA, Gilbert PA, Mi QS, Santamaria P, Dekaban GA, Delovitch TL.
    Diabetes; 2007 Mar 15; 56(3):809-17. PubMed ID: 17327452
    [Abstract] [Full Text] [Related]

  • 40. Inhibition of autoimmune diabetes in nonobese diabetic mice by transgenic restoration of H2-E MHC class II expression: additive, but unequal, involvement of multiple APC subtypes.
    Johnson EA, Silveira P, Chapman HD, Leiter EH, Serreze DV.
    J Immunol; 2001 Aug 15; 167(4):2404-10. PubMed ID: 11490031
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 4.